Le Lézard
Classified in: Health
Subjects: TRI, FDA

icotec AG Granted FDA Clearance To Market VADER®one Pedicle Screw System

ALTSTAETTEN, Switzerland, July 8, 2019 /PRNewswire/ -- icotec AG, a Swiss company, today announced the VADER®one pedicle screw system was granted U.S. Food and Drug Administration (FDA) 510(k) clearance for both minimally-invasive and open spine surgical procedures. VADER®one, made from icotec's unique BlackArmor® material, was designed for secure stabilization and post-operative visualization, which is important after spinal tumor procedures.

VADER®one pedicle system offers clear visualization of the surgical site post-operatively.

In a recent publication, the neurosurgery and radiation oncology group from Technical University of Munich, Germany, stated: "In terms of postoperative evaluation of residual or recurrent tumor within the periphery of the spinal canal and column and for accurate radiation planning, CFRP* implants hold major advantages when compared with standard titanium implants by generating significantly fewer image artifacts." [1]

VADER®one is made from icotec's unique BlackArmor® Carbon/PEEK material, which consists of continuous carbon fibers combined with PEEK (polyetheretherketone), and is produced using icotec's injection molding CFM (Composite Flow Molding) manufacturing technology. This process allows for 3-dimensionally reinforced, nonmetallic implants providing both, the strength and radiolucency needed for oncology patients and their treatment.

icotec is the only company manufacturing spinal implants made of radiolucent BlackArmor® Carbon/PEEK composite material. Implants made of BlackArmor® are biocompatible and have been successfully implanted for over 15 years. Their X-ray, CT and MRI translucency makes a significant difference during the surgical procedure, and postoperatively in assessing the site of care. In patients with spinal tumors, optimal delineation of the tumor from healthy tissue can facilitate radiotherapy planning, improve radiosurgery treatment and allow immediate and precise monitoring of possible relapses (tumor recurrence).

"Our ability to use icotec's BlackArmor® material for stabilizing the spine offers advanced-stage tumor patients the ability to consider a larger variety of treatment options with improved therapy planning, dose delivery and follow-up evaluation," says Roger Stadler, CEO of icotec AG, Switzerland. "It is a great achievement for our company and our employees to obtain FDA clearance, a significant milestone in our company's history."

The VADER®one implants are intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the thoracic and lumbar spine in whom life expectancy is of insufficient duration to permit achievement of fusion.

icotec AG is a family-owned SME in Altstaetten, Switzerland established in 1999. icotec designs and manufactures nonmetallic spinal implants made from BlackArmor® (Carbon/PEEK). More than 10'000 icotec BlackArmor® pedicle screws have been implanted in countries outside the USA since their market introduction.

For more information, visit our website www.icotec-medical.com or contact us at media@icotec-medical.com

* CFRP (carbon fiber-reinforced polyetheretherketone) is identical to Carbon/PEEK.

[1] Ringel, F., et al., Radiolucent carbon-fiber reinforced pedicle screws for the treatment of spinal tumors: Advantages for radiation planning and follow-up imaging. World Neurosurg, 2017.

Lateral x-ray image of a patient stabilized with icotec VADER® pedicle screw system (courtesy of Prof. B. Meyer, TU Munich, Germany)

SOURCE Icotec Medical

These press releases may also interest you

at 04:41
AT & IT China 2020, organized by Informa Markets and China Chamber of Commerce for Import & Export of Medicines & Health Products and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd., to take place at the Shanghai...

at 04:00
Kindful Body, a collaboration of skilled clinicians dedicated to providing compassionate, trauma-informed care for clients suffering from eating disorders, is now offering online eating disorder therapy throughout California. The new virtual group...

at 03:30
TABLE FOR TWO (TFT) USA, a non-profit organization that aims to tackle obesity and global hunger issues, organized its fifth annual social action campaign called ONIGIRI ACTION ? Change the World with Onigiri Rice Balls. The campaign, which...

at 03:22
AT & IT China 2020, organized by Informa Markets and China Chamber of Commerce for Import & Export of Medicines & Health Products and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd., to take place at the Shanghai...

at 03:05
transcosmos inc., USEN CORPORATION (Headquarters: Tokyo, Japan; President and Representative Director: Kimimasa Tamura), a member of USEN-NEXT GROUP, and OTSUMA WOMEN'S UNIVERSITY (Main Campus: Tokyo, Japan; President: Masanao Itoh) have conducted a...

at 03:02
Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced the outcome of a November 20th meeting with the U.S. Food and Drug Administration (FDA) to discuss a regulatory path forward for...

News published on 8 july 2019 at 15:04 and distributed by: